Publications by authors named "Martin Reijans"

Claim this Profile
M
Multi-center evaluation of the novel fully-automated PCR-based Idylla™ BRAF Mutation Test on formalin-fixed paraffin-embedded tissue of malignant melanoma.
Linea Melchior, Morten Grauslund, Beatriz Bellosillo, Clara Montagut, Erica Torres, Martin Reijans

Exp Mol Pathol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF mutation testing with a rapid, fully integrated molecular diagnostics system.
Filip Janku, Bart Claes, Helen J Huang, Gerald S Falchook, Benoit Devogelaere, Martin Reijans

Oncotarget· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human papillomavirus multiplex ligation-dependent probe amplification assay for the assessment of viral load, integration, and gain of telomerase-related genes in cervical malignancies.
Wendy Theelen, Rogier J N T M Litjens, Svetlana Vinokurova, Annick Haesevoets, Martin Reijans

Hum Pathol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of the HPV MLPA assay in cervical cytology for the prediction of high grade lesions.
Rogier J N T M Litjens, Wendy Theelen, Yvonne van de Pas, Jessica Ossel, Martin Reijans

J Med Virol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a new multiplex polymerase chain reaction assay STDFinder for the simultaneous detection of 7 sexually transmitted disease pathogens.
Claude Mambo Muvunyi, Nathalie Dhont, Rita Verhelst, Tania Crucitti, Martin Reijans

Diagn Microbiol Infect Dis· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increase in viral load, viral integration, and gain of telomerase genes during uterine cervical carcinogenesis can be simultaneously assessed by the HPV 16/18 MLPA-assay.
Wendy Theelen, Ernst-Jan M Speel, Michael Herfs, Martin Reijans, Guus Simons

Am J Pathol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new multiparameter assay to assess HPV 16/18, viral load and physical status together with gain of telomerase genes in HPV-related cancers.
Wendy Theelen, Martin Reijans, Guus Simons, Frans C S Ramaekers, Ernst-Jan M Speel

Int J Cancer· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RespiFinder: a new multiparameter test to differentially identify fifteen respiratory viruses.
Martin Reijans, Gijs Dingemans, Corné H Klaassen, Jacques F Meis, Judith Keijdener

J Clin Microbiol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxin profiles and resistances to macrolides and newer fluoroquinolones as epidemicity determinants of clinical isolates of Clostridium difficile from Warsaw, Poland.
Hanna Pituch, Willem van Leeuwen, Kees Maquelin, Dorota Wultańska, Piotr Obuch-Woszczatyński, Martin Reijans

J Clin Microbiol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new high-throughput AFLP approach for identification of new genetic polymorphism in the genome of the clonal microorganism Mycobacterium tuberculosis.
Nicole van den Braak, Guus Simons, Roy Gorkink, Martin Reijans, Kimberly Eadie

J Microbiol Methods· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative comparison of cDNA-AFLP, microarrays, and GeneChip expression data in Saccharomyces cerevisiae.
Martin Reijans, Romeo Lascaris, Antoinette Oude Groeneger, Alexander Wittenberg, Erik Wesselink

Genomics· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis